+
Site Tour

bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian

bRIGHT results support the exceptional safety and effectiveness of TriClip TEER in real-world population at 2 years

Download

LEARN MORE:

EuroPCR Symposium 2025 TriClip

Related Resources

TRILUMINATE Pivotal - 2-year update EuroPCR 25

Prognosis of TR after MitraClip for MR

Poster: Primary MR in the Very Elderly

PCR LV 2021: Navitor™ Live-in-a-box

ESC 2021: HF & VHD Guidelines

Data Summary PFO closure in patients > 60 Years

bRIGHT study

PCR LV 2021: Navitor™ Looking ahead

ESOC presentation: PFO closure in patients > 60 Years

TRENDING TOPICS

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 25, presented by G. Singh

Poster: Primary MR in the Very Elderly

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

CONNEXT


TV
RELATED RESOURCES

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

TriClip - AVVS 1 year 1 minute Tricuspid - Video

TAVI Summit 2023: Morphology

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Trending Topics – Timing

AV VALVES 2023: Fast Forward 20 Years

PremiClose 2024: The PDA, when to intervene

EuroPCR 2023: Tricuspid valve

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline